Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience

Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we...

Full description

Bibliographic Details
Main Authors: Coman, Roxana M., Gotoda, Takuji, Forsmark, Christopher E., Draganov, Peter V.
Format: Online
Language:English
Published: © Georg Thieme Verlag KG 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993890/
id pubmed-4993890
recordtype oai_dc
spelling pubmed-49938902016-08-23 Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience Coman, Roxana M. Gotoda, Takuji Forsmark, Christopher E. Draganov, Peter V. Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we prospectively evaluated the outcomes of ESD in patients with BE with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC) performed in a Western center. © Georg Thieme Verlag KG 2016-06 2016-03-30 /pmc/articles/PMC4993890/ /pubmed/27556083 http://dx.doi.org/10.1055/s-0042-101788 Text en © Thieme Medical Publishers
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Coman, Roxana M.
Gotoda, Takuji
Forsmark, Christopher E.
Draganov, Peter V.
spellingShingle Coman, Roxana M.
Gotoda, Takuji
Forsmark, Christopher E.
Draganov, Peter V.
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
author_facet Coman, Roxana M.
Gotoda, Takuji
Forsmark, Christopher E.
Draganov, Peter V.
author_sort Coman, Roxana M.
title Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
title_short Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
title_full Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
title_fullStr Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
title_full_unstemmed Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
title_sort prospective evaluation of the clinical utility of endoscopic submucosal dissection (esd) in patients with barrett’s esophagus: a western center experience
description Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we prospectively evaluated the outcomes of ESD in patients with BE with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC) performed in a Western center.
publisher © Georg Thieme Verlag KG
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993890/
_version_ 1613632270689632256